Cover Image

Implications of drugs with rebate in Europe

Saved in:

Bibliographic Details
Main Authors:	Andrea Bonetti (Author), Jacopo Giuliani (Author)
Format:	Book
Published:	Elsevier, 2021-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Patients' access to drugs with rebates in Switzerland - Empirical analysis and policy implications for drug pricing in Europe
by: David L Carl, BA, et al.
Published: (2021)

Confidential and non-confidential drug rebates in Switzerland, 2013-2023: empirical analysis of drug rebates, trends over time and re-evaluations
by: Noah Rohner, et al.
Published: (2024)

An exploration of rollover protective structures (ROPS) rebate program media coverage: strategies for implementation and sustainment
by: Pamela J. Tinc, et al.
Published: (2019)

Method: Intention to claim a Medicare rebate among women receiving private Victorian pregnancy termination services
by: Carolyn Nickson, et al.
Published: (2004)

Impact of the Medicare Benefits Schedule Rebate (MBSR) freeze on General Practice (GP) use: multivariable regression analysis
by: Shalika Bohingamu Mudiyanselage, et al.
Published: (2023)

Key factors for successful implementation of the National Rollover Protection Structure Rebate Program: A correlation analysis using the consolidated framework for implementation research
by: Pamela J Tinc, et al.
Published: (2020)

When is a drug-related death not a drug-related death? Implications for current drug-related death policies in the UK and Europe
by: Church Elaine, et al.
Published: (2007)

Aquisição da habilidade motora rebater na educação física escolar: um estudo das dicas de aprendizagem como conteúdo de ensino The acquisition of striking motor skill in school physical education: a study of learning cues as educational content
by: Sérgio Roberto Silveira, et al.
Published: (2013)

Evolving migrant crisis in Europe: implications for health systems
by: Manuel Carballo, et al.
Published: (2017)

Regulating the health workforce in Europe: implications of the COVID-19 pandemic
by: Dimitra Panteli, et al.
Published: (2021)

Policies to enhance prescribing efficiency in Europe: findings and future implications
by: Brian eGodman, et al.
Published: (2011)

The dawn of mesoscopic approach in drug development
by: Alessandro Giuliani
Published: (2011)

Implications of the COVID-19 Pandemic for Pediatric Primary Care Practice in Europe
by: Gottfried Huss, et al.
Published: (2021)

Current and future developments in managed care in the United States and implications for Europe
by: Aspling Deborah L, et al.
Published: (2005)

Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications
by: Nenad Miljković, et al.
Published: (2020)

Social Services Disrupted: Changes, Challenges and Policy Implications for Europe in Times of Austerity
by: Anneli Anttonen
Published: (2017)

The dawn of digital public health in Europe: Implications for public health policy and practice
by: Brian Li Han Wong, et al.
Published: (2022)

Introduction and utilisation of high priced HCV medicines across Europe; implications for the future
by: Winnie de Bruijn, et al.
Published: (2016)

Practice Patterns in Fournier's Gangrene in Europe and Implications for a Prospective Registry Study
by: Laila Schneidewind, et al.
Published: (2023)

Drugs: The portuguese fallacy and the absurd medicalization of Europe
by: Manuel Pinto Coelho
Published: (2015)

Different initiatives across Europe to enhance losartan utilisation post generics: impact and implications
by: James eMoon, et al.
Published: (2014)

"Unicorn horn" drugs in the medical and pharmaceutical culture of Europe
by: mateusz dąsal, et al.
Published: (2021)

A comparative study of orphan drug prices in Europe
by: Katherine Eve Young, et al.
Published: (2017)

Micro-RNA in Cholangiocarcinoma: Implications for Diagnosis, Prognosis, and Therapy
by: Anna Barbato, et al.
Published: (2022)

Review of upcoming and currently available anti-obesity drugs in Europe
by: Patryk Gryszkiewicz, et al.
Published: (2023)

Drug-resistant TB spreading in Eastern Europe and Central Asia

Registration procedure of generic drugs in the Republic of Kazakhstan and Europe: Review
by: Dinara Kaliyeva, et al.
Published: (2022)

Photoprotection and its implications for drug safety
by: Agata Kryczyk-Poprawa, et al.
Published: (2024)

Energy Demand Challenges in Europe Implications for policy, planning and practice /
Published: (2019)

Energy Demand Challenges in Europe Implications for policy, planning and practice
Published: (2019)

Energy Demand Challenges in Europe Implications for policy, planning and practice
Published: (2019)

Energy Demand Challenges in Europe Implications for policy, planning and practice
Published: (2019)

Analytical Challenges and Regulatory Requirements for Nasal Drug Products in Europe and the U.S.
by: Sabrina Trows, et al.
Published: (2014)

Comparing Policies to Enhance Prescribing Efficiency in Europe Through Increasing Generic Utilization: Changes Seen and Global Implications
by: W Shrank, et al.
Published: (2019)

Drug tendering: drug supply and shortage implications for the uptake of biosimilars
by: Dranitsaris G, et al.
Published: (2017)

Europe Faces Europe Narratives from Its Eastern Half
Published: (2017)

Europe Faces Europe Narratives from Its Eastern Half
Published: (2017)

The Cambridge Platonists in Continental Europe Critique and Erudition in the Bibliothèques of Jean Le Clerc
by: Bianchi, Andrea
Published: (2019)

Nuclear Deterrence in Europe Russian Approaches to a New Environment and Implications for the United States
by: Quinlivan, James T.
Published: (2011)

A Scoping Review of Populist Radical Right Parties' Influence on Welfare Policy and its Implications for Population Health in Europe
by: Chiara Rinaldi, et al.
Published: (2021)